Delivery Order SPE2DR25D1022-SPE2DR26FRD6E
- Not listed
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for CABENUVA ER 600 mg–900 mg suspension (6 mL) with a ceiling value of $4,092.11. The order is placed under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply across military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries firm fixed...
- <p>The Defense Logistics Agency issued a $4,092.11 delivery order to AmerisourceBergen Drug Corp on April 23, 2026, for CABENUVA ER 600 mg–900 mg suspension, 6 mL.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of May 14, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $8,184.22 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for CABENUVA ER 600 MG-900 MG suspension (6 mL).</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of May 18, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $40,921.10 delivery order to Amerisourcebergen Drug Corp on April 28, 2026, for CABENUVA ER 600 mg–900 mg suspension (6 ml).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 19, 2026. The source does not identify the parent vehicle by name; the award was issued without set-aside under full and open competition.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,184.22 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on January 15, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- The Defense Logistics Agency awarded a $24.6K delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL) through February 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL formulations. This competitively awarded, non-set-aside firm fixed-price delivery order carries a ceiling value of $19,084.50 and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a $38,169 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for CABENUVA ER 600 MG-900 MG Suspension in 6 mL units. This firm fixed-price delivery order, which represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements, is scheduled for completion by September 18, 2025, with performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with...
- The Defense Logistics Agency awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg–900 mg suspension (6 mL) with a completion date of September 30, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FRD6EDelivery Order
The Defense Logistics Agency issued a $32,736.88 delivery order to Amerisourcebergen Drug Corp on May 7, 2026, for CABENUVA ER 600 mg-900 mg suspension (6 ml), with an ultimate completion date of May 29, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems. The company holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 5/6/26 |